Search - tctmd.com

Displaying 121 - 140 of 238

Sort: Relevancy | Date

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Daily News

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

May 12, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

Presentation

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Presenter: Gregg W. Stone

April 28, 2014

Presentation Fellows 2014

Renal Artery Intervention and Denervation for Resistant Hypertension

Presenter: Duane Pinto

April 14, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

News Conference News ACC 2014

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Yael L. Maxwell

March 29, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Daily News

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

Caitlin E. Cox

January 29, 2014

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2013

Jason Kahn

January 27, 2014

News Industry News

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

January 08, 2014

News Industry News

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

December 16, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

Presentation TCT 2013

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Presenter: Michael Jaff

October 31, 2013

Presentation TCT 2013

Noninvasive Evaluation and Treatment of Resistant Hypertension

Presenter: C. Venkata S. Ram

October 31, 2013

News Conference News TCT 2013

Renal Denervation Systems Show Persistent Reductions in BP

October 30, 2013

Advertisement

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

Renal Denervation Shows Promise in Patients Refractory to Stenting

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Renal Artery Intervention and Denervation for Resistant Hypertension

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

TCTMD’s Top 10 Most Popular News Stories for 2013

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Noninvasive Evaluation and Treatment of Resistant Hypertension

Renal Denervation Systems Show Persistent Reductions in BP

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content